Iguratimod showed superior systemic and serological benefits over hydroxychloroquine in active primary Sjögren’s syndrome
TLR4 rs41426344 CC genotype is linked to higher susceptibility and disease activity in ankylosing spondylitis
Novel severity classification system improves treatment stratification in intestinal Behçet’s disease
Ozoralizumab showed comparable efficacy in rheumatoid arthritis patients with and without large joint involvement
Serum biomarkers identified as potential predictors of baricitinib response in juvenile idiopathic arthritis
Anti-CD38 antibody CM313 demonstrated manageable safety and encouraging efficacy in systemic lupus erythematosus
